View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

FDA's regulatory policy not biased against Indian drug makers

July 17, 2014
Amid news of regulatory action taken by the U.S. watchdog against pharmaceutical companies, at first glance it would appear that mostly Indian companies have come under fire.
Read More

Salix Pharmaceuticals to merge with Cosmo subsidiary

July 16, 2014
U.S.-based Salix Pharmaceuticals Ltd. has announced plans to merge with a unit of Italian company Cosmo Pharmaceuticals, Cosmo Technologies Ltd.
Read More

New FDA requirements to increase costs for Indian drug makers

July 14, 2014
The U.S. Food and Drug Administration (FDA) is introducing more stringent regulation regarding quality standards for drug products manufacturing, which will push up costs for Indian drug producers.
Read More

'High Containment' Powder Handling Solutions

July 14, 2014
Spiroflow Systems specializes in "high containment" powder handling solutions and offer a range of bulk bag unloaders specifically for use in pharmaceutical applications.
Read More

Omnicare to pay $124 million to settle fraud allegations

June 30, 2014
Cincinnati-based Omnicare Inc. is to pay more than $124 million in a settlement with the U.S. Department of Justice for allegedly offering financial incentives to healthcare facilities.
Read More

India's drug makers embrace automation

June 30, 2014
India's second largest drug maker by sales, Dr. Reddy's Laboratories, is embracing automation and making it a critical part of the manufacturing process.
Read More

US regulator to tighten scrutiny on potential drug delay deals

June 24, 2014
The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

British scientists discover way to fight antibiotic-resistant bacteria

June 23, 2014
Thanks to a new study by researchers at the University of East Anglia (UEA), the fight against antibiotic-resistant bacteria may become easier.
Read More

Merck to take over hepatitis C drug maker

June 16, 2014
American pharmaceutical giant Merck & Co. is planning to buy Idenix Pharmaceuticals Inc., a Massachusetts-based company specializing in developing treatment for hepatitis C.
Read More

Hikma Pharmaceuticals to take over US generic injectables manufacturer

June 5, 2014
London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More